10-1-2-3　ⓔ文献

  1. Truong MT, Viswanathan C, et al: Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging, 2011; 26: 132–146.

  2. Ohno Y, Koyama H, et al: Magnetic resonance imaging (MRI) and positron emission tomography (PET)/MRI for lung cancer staging. J Thorac Imaging, 2016; 31: 215–227.

  3. Kandathil A, Kay FU, et al: Role of FDG PET/CT in the Eighth edition of TNM staging of non–small cell lung cancer. Radiographics, 2018; 38: 2134–2149.

  4. Ohno Y: New applications of magnetic resonance imaging for thoracic oncology. Semin Respir Crit Care Med, 2014; 35: 27–40.

  5. Kim HS, Lee KS, et al: PET/CT versus MRI for diagnosis, staging, and follow–up of lung cancer. J Magn Reson Imaging, 2015; 42: 247–260.

  6. Ohno Y, Koyama H, et al: Lung Cancer Assessment Using MR Imaging: an Update. Magn Reson Imaging Clin N Am, 2015; 23: 231–244.

  7. Ciliberto M, Kishida Y, et al: Update of MR Imaging for Evaluation of Lung Cancer. Radiol Clin North Am, 2018; 56: 437–469.

  8. Matsuoka S, Hunsaker AR, et al: Functional MR imaging of the lung. Magn Reson Imaging Clin N Am, 2008; 16: 275–289, ix.

  9. Ohno Y, Koyama H, et al: Contrast–enhanced CT–and MRI–based perfusion assessment for pulmonary diseases: basics and clinical applications. Diagn Interv Radiol, 2016; 22: 407–421.

  10. Ohno Y, Yoshikawa T, et al: Unenhanced and contrast–enhanced MR angiography and perfusion imaging for suspected pulmonary thromboembolism. AJR Am J Roentgenol, 2017; 208: 517–530.

  11. Johns CS, Swift AJ, et al: Pulmonary MR angiography and perfusion imaging–a review of methods and applications. Eur J Radiol, 2017; 86: 361–370.

  12. Ohno Y, Hatabu H, et al: Contrast–enhanced MR perfusion imaging and MR angiography: utility for management of pulmonary arteriovenous malformations for embolotherapy. Eur J Radiol, 2002; 41: 136–146.